Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-11-25

Clinical Trial Update: Comparison Three vs Six Months of Dual Anti-platelet Therapy After Sirolimus-eluting Stent Implantation [NA]

View source ↗

Summary

A trial evaluating 3 versus 6 months of dual antiplatelet therapy after sirolimus-eluting stent implantation for intracranial arteriosclerosis and intracranial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus-eluting stent (sirolimus-eluting stent)

Snippet

Sponsor: Sino Medical Sciences Technology Inc. | Conditions: Intracranial Arteriosclerosis, Intracranial Artery Stenosis | NA | Status: WITHDRAWN